RPG Investment Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$5.77M |
| 2 |
Omega Healthcare
OHI
|
+$5.01M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$2.09M |
| 4 |
SLB Ltd
SLB
|
+$1.54M |
| 5 |
Sabra Healthcare REIT
SBRA
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
B&G Foods
BGS
|
+$6.31M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$4.66M |
| 3 |
FMC
FMC
|
+$4.3M |
| 4 |
ScottsMiracle-Gro
SMG
|
+$3.61M |
| 5 |
Netflix
NFLX
|
+$3.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.59% |
| 2 | Energy | 11.02% |
| 3 | Technology | 10.86% |
| 4 | Communication Services | 9.78% |
| 5 | Healthcare | 9.13% |
Similar funds
RPG Investment Advisory's Q1 2019 Portfolio in Review
As of Q1 2019, RPG Investment Advisory held 309 positions worth $427M, up 6.7% from $401M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RPG Investment Advisory withdrew a net $23.3M in Q1 2019, closing 20 positions and reducing 64 holdings. Its most notable exit was STORE Capital Corporation, an estimated $4.66M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Energy and Technology.
Against the trend, RPG Investment Advisory opened a new position in Omega Healthcare worth $5.16M.
- RPG Investment Advisory's largest Q1 2019 buy was Omega Healthcare: 135,234 shares worth $5.16M.
- RPG Investment Advisory added most to AbbVie in Q1 2019, an estimated $5.77M increase.
- RPG Investment Advisory's biggest Q1 2019 reduction was B&G Foods, cutting an estimated $6.31M.
- RPG Investment Advisory fully exited STORE Capital Corporation in Q1 2019, selling an estimated $4.66M.
- RPG Investment Advisory's ten largest holdings make up 25% of its $427M portfolio in Q1 2019.
- RPG Investment Advisory opened 19 new positions and closed 20 in Q1 2019.
- RPG Investment Advisory's portfolio value rose 6.7% quarter-over-quarter to $427M.
Based on RPG Investment Advisory's 13F filing for Q1 2019, filed 15 Apr 2019.